$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Sep 26, 2025)
$292.50M
Market Cap
-
P/E Ratio
-
EPS
$63.00
52 Week High
$10.83
52 Week Low
HEALTHCARE
Sector
Field | Value |
---|---|
Ex Dividend Date | 2023-01-13 |
Declaration Date | None |
Record Date | None |
Payment Date | None |
Amount | 0.24 |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Crescent Biopharma, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, specializing in the development of novel protease therapeutics for hemostasis and complement regulation. With a strong focus on addressing unmet medical needs, Crescent Biopharma is advancing a robust pipeline of innovative candidates aimed at treating serious conditions related to blood coagulation and immune response. The company is positioned to leverage its cutting-edge research capabilities and proprietary technologies to drive impactful solutions in the biopharmaceutical landscape.